Browse Category

NASDAQ:GMAB News 30 December 2025 - 19 January 2026

AbbVie stock slides after Epkinly trial misses survival goal — what ABBV investors watch next

AbbVie stock slides after Epkinly trial misses survival goal — what ABBV investors watch next

AbbVie shares fell 1.1% to $214.35 Friday after partner Genmab said their blood cancer drug epcoritamab failed to meet the main survival goal in a Phase 3 trial. Genmab’s U.S. shares dropped over 7%. AbbVie reported a benefit for progression-free survival but not overall survival. Investors await AbbVie’s earnings report on Feb. 4.
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout

Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout

Merus N.V. shares were halted Tuesday after Nasdaq confirmed Genmab’s $97-a-share cash acquisition closed, with trading set for suspension Dec. 31. Holders will receive $97 per share minus a $10.67 Dutch dividend withholding tax, leaving about $86.33 before any refund. Merus requested delisting, and two directors resigned as the merger became effective. Genmab’s U.S. shares fell about 2% in late-morning trading.
30 December 2025

Stock Market Today

ASML stock price jumps as AI spending race returns; jobs data and dividend dates ahead

ASML stock price jumps as AI spending race returns; jobs data and dividend dates ahead

8 February 2026
ASML’s U.S.-listed shares jumped 4.6% to $1,413 on Friday, tracking a 5.7% rally in chip stocks after Amazon and Alphabet signaled higher AI infrastructure spending. Peers Applied Materials, Lam Research, and KLA each gained over 6%. ASML’s interim dividend goes ex-dividend Feb. 9 in Amsterdam and Feb. 10 in New York, with payment set for Feb. 18. U.S. jobs and inflation data are due next week.
Ashtead Group share price ends week higher as U.S. listing clock ticks — what to watch next

Ashtead Group share price ends week higher as U.S. listing clock ticks — what to watch next

8 February 2026
Ashtead Group shares closed up 1.1% at 4,936 pence Friday after the company confirmed a new round of share buybacks. The firm expects its U.S. listing to become effective Feb. 26, with a UK share swap on Feb. 27 and new shares trading March 2. FTSE Russell plans to remove Ashtead from its UK indexes from March 2. Index funds are preparing for the change as the company shifts its primary listing to New York.
Beazley share price sits below Zurich’s £8bn offer — what to watch before London reopens

Beazley share price sits below Zurich’s £8bn offer — what to watch before London reopens

8 February 2026
Beazley shares closed flat at 1,236 pence Friday as Zurich faces a Feb. 16 deadline to make a firm takeover offer or withdraw. Zurich and Beazley have agreed in principle on key terms valuing Beazley at up to 1,335 pence per share. Recent filings show Vanguard and FMR LLC among top shareholders. The shares remain below the possible offer price as due diligence continues.
Tesco share price: what to watch after Friday’s close as rate and wage bets shift

Tesco share price: what to watch after Friday’s close as rate and wage bets shift

8 February 2026
Tesco shares closed at 452.10 pence on Friday, up 0.62%, as UK markets ended the week higher. Investors weighed Bank of England signals on interest rates and rising supermarket wage costs, with Lidl and rivals announcing pay increases ahead of April’s minimum wage hike. Morrisons is considering raising up to £1 billion against its store portfolio, according to Sky News. Tesco continues its share buyback program after a January profit forecast upgrade.
Go toTop